Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Agios Reports Neutral Sickle Cell Data, Decides To Stop Development
Agios Pharma to discontinue sickle cell disease treatment development
Agios scraps blood cancer drug program after study miss